🇺🇸 FDA
Patent

US 6033864

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens

expired A61KA61K38/1709A61P

Quick answer

US patent 6033864 (Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens) held by The Regents of the University of California expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/1709, A61P, A61P1/04, A61P37/02